FDA - Food and Drug Administration
New tool designed to detect biases hidden in medical AI data sets, identifies flaws in training
"We train models to be the most predictive, but we have zero control over what the model uses to make the prediction," AI-assisted medicine expert Unberath added.
US FDA says it is investigating another cyclosporiasis outbreak
FDA reverses lettuce warning: Taylor Farms cyclospora test was a false positive
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
US FDA clears Pfizer's COVID booster shot for young children
Children below the age of five are not yet eligible for a COVID-19 vaccine in the United States.
State sues Teva over Copaxone drug royalties
Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
Biogen pulls application for Alzheimer's drug in Europe
The drugmaker said the move follows interactions with the European Medicines Agency that suggested data provided so far would not be enough to support an approval.
Japan's Kowa says Ivermectin showed 'antiviral effect' against Omicron
Clinical trials are ongoing, but promotion of ivermectin as a COVID-19 treatment has generated controversy.
Biogen shares slide as Medicare restricts cover of Alzheimer's treatments
The coverage decision by US Centers for Medicare and Medicaid Services (CMS), the health agency that runs Medicare, crushes any hopes of the drug Aduhelm gaining traction.
Wait 3 days, then swab throat and nose when using antigen test, Health Ministry says
The Health Ministry published new recommendations on how to use the at-home kits, amid criticism for their lack of accuracy.
Controversial Alzheimer's drug administered for first time in Israel
This marks the first time that the drug has been used outside of the United States.
Israeli firm SpliSense moves to clinical trials for cystic fibrosis treatment
"It will improve patients' lung function, reduce lung inflammation, enable them to breathe better, and go back to normal life."
US FDA clears Pfizer's COVID-19 booster shot for 12- to 15-year-olds
The FDA said it reviewed published data and real-world evidence on the safety of booster doses provided by the Israeli Ministry of Health.
